SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Techniclone (TCLN) -- Ignore unavailable to you. Want to Upgrade?


To: Bearcatbob who wrote (2994)4/5/1999 12:38:00 AM
From: GregSL  Read Replies (1) | Respond to of 3702
 
SU-5416 is anti-angiogenisis. It prevents new blood vessels from forming. This tends to limit growth of tumors by depriving them of adequate nutrition. TCLN's Vascular Targeting Agents (VTA) takes advantage of differences in established tumor blood vessels. It exploits these differences to clot-off the tumor and kill it. Check this website and read any postings by Golfdad. He does a great job explaining the science.

clubs.yahoo.com